Rudrriv
Hire Talent Discuss Your Requirement
Pharmaceutical Data Management

Pharmaceutical Data Management Built Around Quality, Traceability & Handoff

4.8/5 · Trusted by 1,250+ customers worldwide

Bring fragmented pharmaceutical data into a clearer operating structure. Rudrriv can support defined data-quality, standardisation, reconciliation, documentation, migration and recurring data-management work — with regulated clinical or submission-related requirements assessed as explicit custom scope.

Source-to-output structureMap what arrives, what changes and what is handed off.
Rule-based quality reviewApply agreed completeness, format, duplicate and consistency checks.
Reconciliation & exceptionsTrack unresolved differences rather than silently overwriting them.
Documented handoffDeliver outputs with rules, issue status, limitations and next actions.
Discuss Your Data Requirement View Engagement Options

Do not send patient-identifiable, credential or other highly sensitive production data in the first enquiry. Describe the scope first so the appropriate transfer workflow can be agreed.

Consolidated Data ReviewVersion 03 · Controlled working copy
Pharma-specific data contextScope built around data domains, systems, downstream use and review roles.
Global service scopeRequirements can be reviewed for multi-market and cross-functional environments.
Custom QuotePricing follows data volume, condition, complexity and required controls.
Scope before sensitive transferFirst define access, confidentiality and handling expectations — then share data.
Engagement Options

Choose the Data-Management Engagement That Matches the Pharma Workflow

Pharmaceutical data work varies too widely for a responsible universal teaser price. Current comparable providers commonly quote by study, data condition, scope and system needs, so this page uses Custom Quote rather than unsupported precision.

Starting price: Custom QuoteFinal price is confirmed only after the data domain, volume, source environment, quality rules, access model, documentation and regulated-use expectations are understood.
Focused / Bounded

Data Quality & Cleanup Sprint

For a defined dataset, extract or pilot where the immediate need is to understand data condition and produce a cleaner, more consistent working output.

Custom Quoteproject scope
  • Data inventory or sample review and agreed cleaning rules
  • Format, completeness, duplicate and consistency checks
  • Exception log plus cleaned / standardised output
  • Focused pilot can often be planned as a short working-day sprint after access is ready
Scope a Cleanup Sprint

Moves to custom complex scope when new systems, major mapping design, regulated submission standards or integration work are required.

Recurring / Operational

Managed Pharma Data Operations

For teams that need a repeatable operating layer around incoming data, agreed checks, reconciliation, exception handling and documented delivery.

Custom Quoterecurring scope
  • Defined intake cadence and data-quality workflow
  • Reconciliation, issue tracking and review-ready outputs
  • Agreed reporting or stewardship documentation
  • Operating schedule aligned to source availability and customer approvals
Discuss Managed Data Support

Best fit when the process is stable enough to define rules, responsibilities, handoffs and review cadence.

Complex / Custom

Migration, Integration or Regulated Data Workstream

For multi-source transitions, system change, study-data requirements or other work where mapping, validation, standards and approvals materially shape delivery.

Custom Quotecomplex scope
  • Source-to-target mapping and transformation logic
  • Reconciliation, validation and acceptance evidence
  • Custom review gates, documentation and handoff
  • Clinical / submission standards considered only when explicitly agreed
Review a Complex Requirement

Direct integration, EDC/database build, formal system validation, biostatistics, medical coding and regulatory publishing are not assumed inclusions.

Record volumeRows, files, studies, products or objects
Source countSystems, vendors and file structures
Data conditionMissing, duplicate, inconsistent or legacy data
Mapping / integrationSource-to-target transformation complexity
Review requirementsValidation, approvals and regulated-use context
UrgencyCutover, database lock or other fixed milestones

Not Sure Which Option Fits Your Data?

Describe the data domain, source environment, approximate volume, current condition and intended use. We can use that information to identify whether the right next step is a bounded quality sprint, managed operation or custom migration / regulated data workstream.

Request a Scope Review
Industry Context

Why Data Management Is Different in Pharmaceuticals

Pharmaceutical data often moves across research, clinical, laboratory, quality, regulatory and operational environments. The value of the work is not just “clean data”; it is preserving meaning, traceability, controlled change and clear ownership as data moves between people, files and systems.

Generic Cleanup Can Miss the Context That Makes a Record Useful

A field can be syntactically valid and still be operationally wrong. Pharmaceutical data management therefore needs rules that understand the object, source, downstream use and review responsibility — not only whether a cell contains a value.

Multiple sources, one downstream decisionEDC, laboratory, quality, vendor, operational and reporting sources may need reconciliation before use.
Meaning must survive transformationRenaming, mapping or converting data should not silently change what the original record meant.
Exceptions need ownershipUnresolved values should be visible, assigned and documented instead of hidden inside a “cleaned” file.
Controls depend on intended useA commercial analysis extract and a regulated clinical record do not necessarily require the same process or evidence.
Common Data Problems We Help Structure
Incomplete identifiersMissing study, product, site, batch or source keys block reliable matching.
Inconsistent formatsDates, units, codes, labels and null conventions vary across sources.
Duplicate / superseded rowsMultiple versions exist without a clear status or precedence rule.
Source mismatchCounts or key values differ between source systems or vendor files.
Traceability gapThe transformation logic or reason for a correction is not documented.
Handoff ambiguityTeams receive a file but not the rules, open issues, version or limitations.
What This Service Can Cover

Data-Management Work Mapped to the Pharmaceutical Data Lifecycle

The exact set is confirmed by scope. These are practical work areas, not a claim that every project requires every activity.

Data Inventory & Profiling

Understand sources, fields, volume, data condition, key objects and known quality problems before changing data.

Common scope

Mapping & Standardisation

Define source-to-target rules, field conventions, controlled values and transformation logic appropriate to the use case.

Common scope

Cleaning & Validation Checks

Apply agreed completeness, type, range, format, duplicate and consistency checks with visible exceptions.

Common scope

Cross-Source Reconciliation

Compare counts, identifiers or agreed fields across source extracts and record unresolved differences.

Common scope

Data Dictionary & Metadata

Document field meaning, allowed values, source, transformation notes and ownership where the project requires it.

By scope

Exception / Query Tracking

Separate unresolved items from completed work and make ownership, status and resolution logic clear.

Common scope

Migration Preparation

Support inventory, mapping, transformation, validation and cutover-readiness activities for agreed data moves.

Custom scope

Structured Data Exchange

Work with approved structured exports or exchange formats where the source, target and acceptance criteria are known.

Custom scope

Data Quality Reporting

Summarise counts, exceptions, completion status, quality-rule results or operational metrics defined in the engagement.

By scope

Controlled Handoff & Stewardship

Version outputs, document known limitations and transition to customer owners or an agreed recurring support cadence.

Common scope
Two Critical Deep Dives

The Work That Prevents “Clean” Data From Becoming Untraceable Data

Two areas become especially important in pharmaceutical environments: preserving source-to-output lineage, and separating general data operations from requirements that belong to clinical, submission or other regulated-use workflows.

Deep Dive 1 — Data Lineage & Controlled Change

Every meaningful change should have a reason, rule and destination — especially when the output feeds another team, system or decision.

1
Identify the authoritative sourceDefine which file/system and version a field or object came from.
2
Write the transformation ruleMap, standardise or derive only according to agreed logic.
3
Preserve exceptionsDo not invent missing meaning; flag records that cannot be resolved safely.
4
Version the handoffMake the output, open issues and applied rules identifiable to the receiving team.

Deep Dive 2 — Standards & Regulated-Use Boundaries

Clinical-study and regulatory submission data can carry additional standard, system and review expectations that should be explicit before work starts.

1
Confirm intended useOperational analysis, study conduct, statistical analysis and regulatory submission are not interchangeable contexts.
2
Confirm applicable standardsWhere required, identify CDISC, customer SOPs, regulator data standards or system controls before building rules.
3
Confirm qualified approvalsRudrriv support does not replace sponsor, medical, statistical, quality or regulatory responsibility.
4
Scope validation evidence separatelyComputer-system validation, formal certification or regulatory sign-off is not assumed within routine data management.
FDA Study Data Standards FDA 21 CFR Part 11 Guidance CDISC SDTM CDISC ADaM CDISC Data Exchange / ODM ICH E6(R3) via EMA
Pharma Data Journey

A Source-to-Handoff Workflow That Keeps Decisions Visible

The lifecycle can be adjusted for a one-time dataset, recurring operation or migration. The important point is to define the gates rather than treating data management as one undifferentiated “cleanup” task.

1Source & ScopeIdentify data owner, source, intended use and acceptance criteria.
2InventoryProfile fields, volume, versions, keys and known issues.
3MapDefine target structure, terminology and transformation rules.
4ProcessClean, standardise or transform the agreed data.
5ValidateRun completeness, consistency and rule-based checks.
6ReconcileCompare agreed sources and record unresolved exceptions.
7ReviewResolve or approve exceptions with the right stakeholders.
8HandoffDeliver versioned outputs, documentation and open-item status.
Data Transformation

From Incoming Data to a Handoff-Ready Dataset

The service should make the state of the data clearer at each stage. It should not make unresolved problems disappear from view.

State 1

Incoming / Source Data

  • Mixed structures and naming
  • Missing or inconsistent keys
  • Duplicates or superseded versions
  • Unclear null / status conventions
  • Cross-source mismatches not yet reconciled
State 2

Validated Working Dataset

  • Agreed mapping and cleaning rules applied
  • Quality checks recorded
  • Exceptions separated from resolved data
  • Transformation logic documented
  • Stakeholder questions visible
State 3

Handoff-Ready Output

  • Version and intended use identified
  • Accepted rules and structure documented
  • Open exceptions disclosed
  • Supporting dictionary / log supplied where scoped
  • Next owner or recurring workflow confirmed
What You Provide · What We Do · What You Receive

Make Scope Concrete Before Data Starts Moving

A good data-management engagement separates customer inputs, service activity and final outputs so that responsibilities do not become blurred during review.

What You Provide

Enough context to identify the data, the owner, the source and the decision the output needs to support.

  • Approved files, extracts or authorised access
  • Source-system and field context
  • Existing dictionaries, code lists or mapping rules
  • Acceptance criteria and downstream use
  • Stakeholder availability for unresolved questions

What Rudrriv Does

The operational data work that has been explicitly agreed — not hidden regulated, medical or statistical responsibilities.

  • Inventory, profile and map the agreed data
  • Apply defined cleaning / standardisation rules
  • Run agreed quality and reconciliation checks
  • Track exceptions and review decisions
  • Prepare documented output for handoff or recurring use

What You Receive

Deliverables depend on scope, but the handoff should make the status of the data and supporting evidence clear.

  • Cleaned / standardised / transformed dataset where applicable
  • Mapping specification or data dictionary where scoped
  • Validation, reconciliation or exception log
  • Quality summary or status report where scoped
  • Handoff notes, limitations and open-item status
Systems, Files & Data Objects

Your Data Environment Shapes the Work

The categories below are examples of environments and formats that may affect a pharmaceutical data-management scope. They do not imply a platform partnership or automatic direct integration.

EDC / Study Data

Clinical data exports, subject / visit structures and study metadata.

CTMS / Site Data

Study, site, milestone, investigator or operational tracking exports.

eTMF / Document Index

Document metadata, taxonomy, status and completeness listings.

LIMS / Laboratory

Sample, test, result, unit and reference-range structured data.

QMS / Quality Data

Controlled metadata, issue, deviation or quality-record extracts.

Safety / PV Data

Safety-related structured data may require separately qualified scope and responsibilities.

ERP / Product Master

Product, material, batch, supplier or operational master/reference data.

CSV / XLSX

Structured flat-file exports used for review, migration or controlled handoff.

XML / JSON

Structured exchange formats where schemas and data meaning are known.

SAS XPT / Submission Data

Relevant only when the regulated study-data scope and standards are explicitly agreed.

APIs / SFTP / Secure Exchange

Integration and transfer mechanisms are custom scope with customer security approval.

BI / Reporting Outputs

Curated extracts, quality metrics or reporting datasets for agreed downstream use.

Quality & Review Methodology

A Multi-Layer Review Before Handoff

The exact checks depend on the dataset and acceptance criteria. A rule should be testable, an exception should be visible, and a final handoff should state what was and was not resolved.

1. Structural Review
  • Fields & data types
  • Required keys
  • File / table structure
  • Version identification
2. Quality Rules
  • Completeness
  • Duplicates
  • Ranges / formats
  • Controlled values
3. Reconciliation
  • Source counts
  • Cross-source keys
  • Agreed field matches
  • Exception capture
4. Reviewer Gate
  • Owner decisions
  • Mapping approval
  • Open-item status
  • Change confirmation
5. Handoff Verification
  • Output version
  • Rule / log package
  • Known limitations
  • Next owner / cadence
Scope Boundaries

Know What Is Standard, What Needs Custom Scoping & What Requires Other Specialists

Clear boundaries matter in a regulated industry. They prevent data-management support from being mistaken for medical, statistical, legal, validation or regulatory authority.

Standard Data-Management Scope

  • Data inventory and profiling
  • Agreed mapping / standardisation rules
  • Defined cleaning and quality checks
  • Reconciliation against agreed sources
  • Exception tracking and review support
  • Documented data handoff

Custom Scope

  • Large or complex migrations
  • Direct system integration / production cutover
  • EDC / database design or build
  • CDISC / submission-oriented dataset work
  • Medical coding or safety data workflows
  • Validation evidence and specialised review gates

Not Assumed / Separate Responsibility

  • Medical or clinical decision-making
  • Biostatistical analysis and interpretation
  • Pharmacovigilance case processing
  • Legal / privacy advice
  • Regulatory submission approval or sign-off
  • Guaranteed compliance, certification or inspection outcome
Regulated-Industry Caution

Regulatory Context Should Be Defined, Not Assumed

For data used in clinical research or regulatory submissions, applicable expectations can include GCP, electronic-record controls, regulator data standards and CDISC models. The correct obligations depend on the project, jurisdiction, record type and intended use. Rudrriv does not present general data-management support as regulatory certification or legal compliance advice.

FDA Study Data Standards

FDA maintains study-data standards resources and technical conformance guidance for electronic study-data submissions across relevant centres.

View FDA resources →

21 CFR Part 11

FDA Part 11 guidance addresses the scope and application of electronic records and electronic signatures under applicable predicate rules.

View FDA guidance →

CDISC Data Standards

CDISC standards such as SDTM, ADaM and data-exchange standards support structured clinical-study data and regulatory review workflows when applicable.

View CDISC standards →

ICH E6(R3) GCP

ICH E6(R3) is the current Good Clinical Practice guideline in regions that have implemented it; responsibilities still depend on the trial and regulatory context.

View current EMA / ICH context →
Who Buys This & Why Now

Typical Stakeholders & Purchase Triggers in Pharmaceutical Organisations

The data owner varies by use case. The buyer is often the team facing a deadline, quality problem, migration, recurring workload or handoff gap — while other stakeholders influence standards, security, acceptance criteria or approvals.

Roles That May Participate

Clinical Data / Biometrics
Clinical Operations
Regulatory Operations
Quality / Compliance
Data / IT / Analytics
Product / Supply / Operations

Common Triggers for External Support

01
Data is blocking a milestoneDatabase lock, migration, reporting, audit preparation, system transition or another fixed decision point is approaching.
02
Multiple sources do not reconcileTeams are spending time comparing exports manually without a stable rule set or exception workflow.
03
Legacy data needs to moveHistorical structures, code lists or incomplete metadata make migration and reuse risky without mapping and validation.
04
Internal teams need operating capacityRecurring intake, checking, reconciliation or reporting work is consuming specialist time that could be focused elsewhere.
Turnaround & Scheduling

Timing Depends on Data Readiness More Than a Calendar Promise

Because the supplied service did not include an approved delivery time and comparable pharmaceutical data-management work is highly scope-dependent, final timing is confirmed after data inventory / sample review and access readiness.

Focused Quality Sprint

For a bounded, accessible dataset with clear rules and prompt stakeholder answers.

Estimated short working-day sprint

Priority Review

For an urgent milestone where scope can be isolated and decision-makers are available.

Feasibility confirmed first

Recurring Operations

For ongoing intake and review after an initial onboarding, rule definition and handoff design period.

Cadence-based delivery

Factors That Change the Schedule

  • Number and size of sources
  • Access / export readiness
  • Mapping complexity
  • Condition of legacy data
  • Exception volume
  • Stakeholder response time
  • Integration / cutover work
  • Regulated-use review needs
  • Rework after source changes
  • Fixed study / business milestones
Frequently Asked Questions

Pharmaceutical Data Management — Buyer Questions

These answers are written for pharmaceutical data-management purchasing decisions, including scope boundaries, systems, pricing, timing, sensitive data and regulated-use requirements.

What does pharmaceutical data management cover?

The exact scope depends on the data lifecycle and intended use. A project may include data inventory, source mapping, cleaning rules, standardisation, validation checks, reconciliation, exception tracking, documentation, controlled handoff and recurring stewardship. Clinical-study or regulated-submission activities are separately scoped where relevant.

Is this service only for clinical trial data?

No. Pharmaceutical organisations may also need support for research, laboratory, quality, product, operational, commercial, vendor or master/reference data. The enquiry review is used to identify the data domain and whether specialist clinical or regulatory scope is required.

Can Rudrriv work with exports from EDC, CTMS, eTMF, LIMS, QMS, safety or ERP systems?

Potentially, yes, when the customer can provide authorised access or approved exports and the formats are suitable for the agreed work. System-specific configuration, validated integration or direct production access is confirmed separately rather than assumed.

Can you clean legacy spreadsheets, CSV files and inconsistent data extracts?

A defined cleanup and standardisation scope can cover spreadsheets and structured extracts, including duplicates, missing fields, inconsistent formats, mapping issues and documented exceptions. The rules and acceptance criteria should be agreed before production changes are made.

Do you support CDISC standards such as SDTM, ADaM or ODM?

CDISC standards can be relevant to clinical-study and submission workflows. If your project requires SDTM, ADaM, ODM, Define-XML or related standards, state that requirement in the enquiry so the scope can be assessed. It is not treated as automatically included in general data-management work.

Is EDC database design or build included?

Not by default. EDC design, CRF/eCRF build, edit-check programming, UAT, validated-system configuration and database lock activities can materially change the project and require an explicitly agreed custom scope.

Does this service guarantee 21 CFR Part 11 or other regulatory compliance?

No. Rudrriv does not represent routine data-management support as a regulatory certification or guarantee. Applicable obligations depend on the records, systems, intended use, jurisdiction and sponsor procedures. Compliance ownership and regulated approvals remain with the responsible customer and qualified stakeholders unless a separate verified scope states otherwise.

Can we send patient-identifiable or other highly sensitive information with the enquiry?

Please do not send highly sensitive, patient-identifiable, credential or production data in the first enquiry. Describe the requirement first. Any later data transfer should follow an agreed access, confidentiality and security workflow appropriate to the project.

What information should we provide to scope the work?

Useful context includes the data domain, source systems or file types, approximate volume, current data condition, intended downstream use, required standards, review or approval roles, known deadlines and whether the work is a one-time cleanup, migration or recurring operation. Put this context in Requirement Details rather than uploading sensitive files initially.

How is pharmaceutical data-management pricing determined?

Pricing is scope-based because effort changes with record volume, source count, data condition, mapping complexity, validation and reconciliation rules, integrations, documentation depth, stakeholder reviews, urgency and regulated-use expectations. A custom quote is confirmed after scope review.

How long does a project take?

Timing is confirmed after reviewing the data sample or inventory, access readiness, volume and acceptance criteria. A focused cleanup or data-quality pilot can often be planned as a short working-day sprint, while migrations, integrations, recurring operations or study-wide data workflows require a custom schedule.

How are corrections and change requests handled?

Issues found against agreed rules are tracked and resolved through the review workflow. A correction to the agreed scope is different from a new mapping rule, new source, new data domain or materially changed acceptance criterion; those changes may require scope and timeline re-confirmation.

What deliverables can we receive?

Depending on scope, deliverables may include cleaned or standardised datasets, mapping specifications, data dictionaries, validation or exception logs, reconciliation outputs, issue trackers, handoff notes, data-quality summaries and operating documentation. Exact formats are agreed before work starts.

What happens at handoff?

The handoff should identify the delivered dataset or output version, outstanding exceptions, applied rules, known limitations, supporting documentation and any customer actions still required. Where recurring support is agreed, the handoff can transition into an operating cadence instead of ending the engagement.

Is ongoing or managed data support available?

Recurring data intake, quality review, reconciliation, reporting support or stewardship can be considered as a managed engagement when the process, access model, service boundaries and review cadence are clearly defined.

When might this service not be enough?

A broader specialist engagement may be needed for full clinical database build, biostatistics, medical coding, pharmacovigilance case processing, regulatory submission publishing, computer-system validation, legal/privacy advice, clinical monitoring or formal regulatory sign-off. These should not be assumed within routine data-management scope.

Can you support a data migration or system change?

Migration support can be scoped when source and target structures, mapping rules, volumes, validation expectations, cutover responsibilities and acceptance checks are known. Direct system integration and production cutover are custom work rather than default inclusions.

What happens after we submit the enquiry?

Rudrriv reviews the data domain, intended use, source environment, sensitivity, volume, quality requirements, standards, timeline and boundaries. The next step is to confirm whether a focused sprint, recurring data operation or custom migration/integration scope is appropriate before pricing and delivery are finalised.

Pharmaceutical Data Management Enquiry

Request a Data Scope Review

Only the four allowed customer-detail fields are shown. Email ID, Phone and Requirement Details are required; Name is optional.

Human verification What is 7 + 5?

The arithmetic check is validated on the server before the approved enquiry endpoint is called. Project data should only be transferred after scope and handling requirements are agreed.